Skip to search formSkip to main contentSkip to account menu

mercaptopurine/methotrexate/prednisone/vincristine protocol

Known as: POMP protocol, MP/MTX/PRED/VCR, Mercaptopurine/Methotrexate/Prednisone/Vincristine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Background The hyper-CVAD regimen is an effective frontline program for de novo adult ALL. Expression of CD20 was identified as… 
2007
2007
Abstract The present study investigated the presence and location of fluorescent microspheres having the size of mouse hepatitis… 
1992
1992
Between August 1978 and September 1982, 642 patients with newly diagnosed acute myelogenous leukemia (AML) were entered onto a… 
1991
1991
The prodrug p-[N,N-bis(2-chloroethyl)amino]phenyl phosphate (phenol mustard phosphate, POMP) was prepared from p-[N,N-bis(2… 
Highly Cited
1987
Highly Cited
1987
The effect of maintenance chemotherapy on remission duration was analyzed in 39 of 70 patients (56%) with acute promyelocytic… 
1975
1975
This study was designed to compare vincristine‐prednisone (VP) vs. prednisolone, vincristine, methotrexate, and 6‐mercaptopurine…